CRESCENT BIOPHARMA INC.
Q4 2025 13F Holders
Symbol
CBIO
CUSIP
38000Q201
Type
Equity
Class
COM
Num filings
2
Total reported value, excl. options
$161 k
Compare 2025 Q4 to
2026 Q2
2026 Q1
Manager
Report Date
Value ($000)
Shares
Option Type